ghk-cu human clinical trial injection “Is actually worth it?” is genuinely one of the most common questions in my comments, so let me finally answer it properly., The short version: copper peptides have real research behind them, Epigenetic mechanisms activated by GHK-Cu

Always follow copper peptides with rich moisturizer

Low Starting Amount Amount per injection: 1.0 mg 3 units (0.03 mL) on a U-100 insulin syringe Frequency: Once daily, under the skin (MonFri, weekends off) Cycle length: 812 weeks, then 24 weeks off Sources: [1] Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data NIH / PMC

Abid Husain, M.D., a triple-board-certified physician specializing in peptide therapy who will be presenting at the meeting, says its outcome could open a safer pathway for consumers, many of whom are currently buying unregulated grey-market peptides online, which often contain the wrong dosage, harmful contaminants, or completely different substances

The blood-vessel signaling associated with GHK-Cu, BPC-157, and TB-4 creates a theoretical concern, not a measured human tumor risk